[PubMed] [Google Scholar] 38.Younes MN, Myers JN
However, since the clinical trial combines several active ingredients with complementary properties, it is difficult to attribute the observed benefits specifically to L-carnitine
Contains no sugar, starch, salt, preservatives, or artificial color, flavor, or fragrance
In summary, our preclinical evaluation of psilocybin for the treatment of obesity and binge-eating disorders demonstrates that psilocybin does not lower body weight and food intake in obese mice, but a single high dose of psilocybin does lower the preference for sucrose in lean mice
10.1002/mds.23148 166 SongL.ChenL.ZhangX.LiJ.LeW
The FDAs Pharmacy Compounding Advisory Committee is scheduled to review their Category 1 eligibility in July 2026